A cross-neutralizing antibody between HIV-1 and influenza virus
A cross-neutralizing antibody between HIV-1 and influenza virus
Incessant antigenic evolution enables the persistence and spread of influenza virus in the human population. As the principal target of the immune response, the hemagglutinin (HA) surface antigen on influenza viruses continuously acquires and replaces N-linked glycosylation sites to shield immunogenic protein epitopes using host-derived glycans. Anti-glycan antibodies, such as 2G12, target the HIV-1 envelope protein (Env), which is even more extensively glycosylated and contains under-processed oligomannose-type clusters on its dense glycan shield. Here, we illustrate that 2G12 can also neutralize human seasonal influenza A H3N2 viruses that have evolved to present similar oligomannose-type clusters on their HAs from around 20 years after the 1968 pandemic. Using structural biology and mass spectrometric approaches, we find that two N-glycosylation sites close to the receptor binding site (RBS) on influenza hemagglutinin represent the oligomannose cluster recognized by 2G12. One of these glycan sites is highly conserved in all human H3N2 strains and the other emerged during virus evolution. These two N-glycosylation sites have also become crucial for fitness of recent H3N2 strains. These findings shed light on the evolution of the glycan shield on influenza virus and suggest 2G12-like antibodies can potentially act as broad neutralizers to target human enveloped viruses.
Lee, Chang-Chun D
e3d41bc1-1df8-420a-b541-6fbaedc7cbd3
Watanabe, Yasunori
8c0ee4af-a293-4de5-9036-3ce2051b380c
Wu, Nicholas C
9e9206f7-19a1-46b9-83ea-6eab7f5a65a4
Han, Julianna
1d0cd5e2-8ea4-41f7-a397-096488113c9d
Kumar, Sonu
3ef7ede8-6dcc-4ce3-8ab5-70e67b230ba7
Pholcharee, Tossapol
9ba0f804-1b66-4564-b609-f0cce8e0e47b
Seabright, Gemma E
09e75998-09b0-465f-a059-c89b07f3b2c3
Allen, Joel D
c89d5569-7659-4835-b535-c9586e956b3a
Lin, Chih-Wei
793d0edb-1215-4559-a761-fe8b12603854
Yang, Ji-Rong
c050e83b-1ce0-4bac-b721-18e9d1bbbb90
Liu, Ming-Tsan
f6e222e9-bc2a-4769-bbb9-9cfa64376e7c
Wu, Chung-Yi
a1abb5e9-79d6-4592-bda7-bf8381f8132e
Ward, Andrew B
78ce5b6a-b852-4ee4-a950-f7ff7b183d83
Crispin, Max
cd980957-0943-4b89-b2b2-710f01f33bc9
Wilson, Ian A
7865d500-d638-4a67-ad6d-fefad0ae83bb
22 March 2021
Lee, Chang-Chun D
e3d41bc1-1df8-420a-b541-6fbaedc7cbd3
Watanabe, Yasunori
8c0ee4af-a293-4de5-9036-3ce2051b380c
Wu, Nicholas C
9e9206f7-19a1-46b9-83ea-6eab7f5a65a4
Han, Julianna
1d0cd5e2-8ea4-41f7-a397-096488113c9d
Kumar, Sonu
3ef7ede8-6dcc-4ce3-8ab5-70e67b230ba7
Pholcharee, Tossapol
9ba0f804-1b66-4564-b609-f0cce8e0e47b
Seabright, Gemma E
09e75998-09b0-465f-a059-c89b07f3b2c3
Allen, Joel D
c89d5569-7659-4835-b535-c9586e956b3a
Lin, Chih-Wei
793d0edb-1215-4559-a761-fe8b12603854
Yang, Ji-Rong
c050e83b-1ce0-4bac-b721-18e9d1bbbb90
Liu, Ming-Tsan
f6e222e9-bc2a-4769-bbb9-9cfa64376e7c
Wu, Chung-Yi
a1abb5e9-79d6-4592-bda7-bf8381f8132e
Ward, Andrew B
78ce5b6a-b852-4ee4-a950-f7ff7b183d83
Crispin, Max
cd980957-0943-4b89-b2b2-710f01f33bc9
Wilson, Ian A
7865d500-d638-4a67-ad6d-fefad0ae83bb
Lee, Chang-Chun D, Watanabe, Yasunori, Wu, Nicholas C, Han, Julianna, Kumar, Sonu, Pholcharee, Tossapol, Seabright, Gemma E, Allen, Joel D, Lin, Chih-Wei, Yang, Ji-Rong, Liu, Ming-Tsan, Wu, Chung-Yi, Ward, Andrew B, Crispin, Max and Wilson, Ian A
(2021)
A cross-neutralizing antibody between HIV-1 and influenza virus.
PLOS Pathogens, 17 (3), [1009407].
(doi:10.1371/journal.ppat.1009407).
Abstract
Incessant antigenic evolution enables the persistence and spread of influenza virus in the human population. As the principal target of the immune response, the hemagglutinin (HA) surface antigen on influenza viruses continuously acquires and replaces N-linked glycosylation sites to shield immunogenic protein epitopes using host-derived glycans. Anti-glycan antibodies, such as 2G12, target the HIV-1 envelope protein (Env), which is even more extensively glycosylated and contains under-processed oligomannose-type clusters on its dense glycan shield. Here, we illustrate that 2G12 can also neutralize human seasonal influenza A H3N2 viruses that have evolved to present similar oligomannose-type clusters on their HAs from around 20 years after the 1968 pandemic. Using structural biology and mass spectrometric approaches, we find that two N-glycosylation sites close to the receptor binding site (RBS) on influenza hemagglutinin represent the oligomannose cluster recognized by 2G12. One of these glycan sites is highly conserved in all human H3N2 strains and the other emerged during virus evolution. These two N-glycosylation sites have also become crucial for fitness of recent H3N2 strains. These findings shed light on the evolution of the glycan shield on influenza virus and suggest 2G12-like antibodies can potentially act as broad neutralizers to target human enveloped viruses.
Text
journal.ppat.1009407
- Version of Record
More information
Accepted/In Press date: 17 February 2021
e-pub ahead of print date: 22 March 2021
Published date: 22 March 2021
Additional Information:
Publisher Copyright:
© 2021 Public Library of Science. All rights reserved.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
Identifiers
Local EPrints ID: 448966
URI: http://eprints.soton.ac.uk/id/eprint/448966
ISSN: 1553-7366
PURE UUID: fc129df5-d56c-4124-9b1d-0328ac586208
Catalogue record
Date deposited: 12 May 2021 16:31
Last modified: 17 Mar 2024 04:09
Export record
Altmetrics
Contributors
Author:
Chang-Chun D Lee
Author:
Yasunori Watanabe
Author:
Nicholas C Wu
Author:
Julianna Han
Author:
Sonu Kumar
Author:
Tossapol Pholcharee
Author:
Gemma E Seabright
Author:
Chih-Wei Lin
Author:
Ji-Rong Yang
Author:
Ming-Tsan Liu
Author:
Chung-Yi Wu
Author:
Andrew B Ward
Author:
Ian A Wilson
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics